Dosimetry for fractionated 131I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results

被引:0
|
作者
Buckley, S. [1 ]
Flux, G. [1 ]
Gaze, M. [2 ]
Chittenden, S. [1 ]
Partridge, M. [1 ]
Lancaster, D. [1 ]
Pearson, A. [3 ]
Saran, F. [1 ]
机构
[1] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[2] UCL Hosp, London, England
[3] Inst Canc Res, Sutton, Surrey, England
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S339 / S339
页数:1
相关论文
共 50 条
  • [41] A safety and feasibility trial of 131I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study
    Weiss, Brian D.
    Yanik, Gregory
    Naranjo, Arlene
    Zhang, Fan F.
    Fitzgerald, Wendy
    Shulkin, Barry L.
    Parisi, Marguerite T.
    Russell, Heidi
    Grupp, Stephan
    Pater, Luke
    Mattei, Peter
    Mosse, Yael
    Lai, Hollie A.
    Jarzembowski, Jason A.
    Shimada, Hiroyuki
    Villablanca, Judith G.
    Giller, Roger
    Bagatell, Rochelle
    Park, Julie R.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (10)
  • [42] Biologically effective dose in fractionated molecular radiotherapy-application to treatment of neuroblastoma with 131I-mIBG
    Minguez, Pablo
    Gustafsson, Johan
    Flux, Glenn
    Gleisner, Katarina Sjogreen
    PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (06): : 2532 - 2551
  • [43] Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
    Buckley, Susan E.
    Chittenden, Sarah J.
    Saran, Frank H.
    Meller, Simon T.
    Flux, Glenn D.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) : 1518 - 1524
  • [44] 177Lu-DOTATATE radionuclide therapy for pediatric patients with relapsed high-risk neuroblastoma negative on 131I-MIBG imaging - a pilot study
    Chen, Sirong
    Cheung, William
    Leung, Yim Lung
    Cheng, Kam
    Wong, Ka Nin
    Wong, Yuet Hung
    Ho, Chi-Lai
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [45] Is Overexpression of the Plasma Membrane Transporter (SLC29A4) a New Option to Stratify Patients with High-Risk Neuroblastoma for Treatment with 131I-mIBG?
    Evers, Raymond
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 387 (03): : 236 - 238
  • [46] Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation with TTC/MEC REGIMENS ± 131I-MIBG for High-Risk Neuroblastoma
    Park, H. J.
    Choi, J. Y.
    Kang, H. J.
    Kim, B. K.
    Hong, K. T.
    Kim, H. Y.
    Kim, I. H.
    Cheon, G. J.
    Cheon, J. E.
    Park, S. H.
    Shin, H. Y.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S338 - S338
  • [47] Feasibility of Administering High-Dose 131I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms
    Chu, Bae P.
    Horan, Christopher
    Basu, Ellen
    Dauer, Lawrence
    Williamson, Matthew
    Carrasquillo, Jorge A.
    Pandit-Taskar, Neeta
    Modak, Shakeel
    PEDIATRIC BLOOD & CANCER, 2016, 63 (05) : 801 - 807
  • [48] Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma
    Mastrangelo, Stefano
    Romano, Alberto
    Attina, Giorgio
    Maurizi, Palma
    Ruggiero, Antonio
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
  • [49] HIGH DOSES I131-MIBG TREATMENT IN THE PEDIATRIC PATIENT WITH HIGH-RISK NEUROBLASTOMA
    Garcia Ariza, Miguel
    Garcia, Lina
    Villa, Marta
    Alonso De Caso, Paloma
    Mitjavila, Mercedes
    Lopez Ibor, Blanca
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 787 - 787
  • [50] A correlation study between clinical outcome and absorbed dose to organs at risk and lesions for patients with High-Risk Neuroblastoma administered with high-activity therapy of 131I-mIBG
    Cassano, B.
    Pizzoferro, M.
    Valeri, S.
    Donatiello, S.
    Polito, C.
    Ciucci, D.
    Martire, F.
    Castellano, A.
    Altini, C.
    Garganese, M. C.
    Cannata, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S315 - S316